On April 25, 2024, BenTre Pharmaceutical Joint Stock Company announced the resolution of annual general meeting 2024 to approve the business plan in 2024. For the year, on Consolidated basis, the company expects revenue of VND 1,095 billion and Profit after tax of VND 44.5 billion. On Separate basis, the company expects revenue of VND 1,100 billion and Profit after tax of VND 49.5 billion.